Apply for the EFIC-Grünenthal Grant (E-G-G) 2021!

Apply for the EFIC-Grünenthal Grant (E-G-G) 2021!

The EFIC-Grünenthal-Grant (E-G-G) is now accepting applications. Early-career scientists from across Europe can submit their innovative research projects in the area of chronic pain to be considered for a research grant from this prestigious scheme. How does it work?...
EFIC-Grünenthal-Grant (E-G-G) Relaunching in 2020

EFIC-Grünenthal-Grant (E-G-G) Relaunching in 2020

In February 2020, the EFIC-Grünenthal Grant (E-G-G) will reopen applications for its pain research grant worth a total of €200,000. E-G-G is a research grant scheme awarded by the European Pain Federation EFIC and sponsored by the pharmaceutical company Grünenthal...
Meet E-G-G Symposium Speaker: Joukje Oosterman, PhD

Meet E-G-G Symposium Speaker: Joukje Oosterman, PhD

“It’s easy for researchers to be confined by their research questions,” says E-G-G winner Joukje Oosterman, PhD. Joukje is a research psychologist with a specialty in the fields of ageing, pain and cognitive performance. However, in the development of the E-G-G...
Meet E-G-G Winner 2018: Jonas Zaman, PhD

Meet E-G-G Winner 2018: Jonas Zaman, PhD

“Science knows no country, because knowledge belongs to humanity.” – Louis Pasteur Like many researchers, E-G-G winner Jonas Zaman, PhD, moved around a lot for his studies – first completing his Psychology degree in Brussels, a Masters in Neuroscience in Maastricht,...
Meet E-G-G Symposium Speaker: Susanne Becker, PhD

Meet E-G-G Symposium Speaker: Susanne Becker, PhD

What is the role of dopamine, or a lack of dopamine, in the development of chronic pain? This was the question posed by Susanne Becker, PhD, one of the winners of the 2016 EFIC-Grünenthal Grant (E-G-G). The subsequent experiment used a dopamine receptor antagonist in...

Subscribe to the European Pain Federation Newsletter!

Don't worry, we will not spam you, you can unsubscribe at any time.

For more information on the transmission and use of your personal data, please refer to our privacy policy.Pr.

You have Successfully Subscribed!